These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1605618)

  • 1. Comparison of antifungal activity of amphotericin B deoxycholate suspension with that of amphotericin B cholesteryl sulfate colloidal dispersion.
    Hanson LH; Stevens DA
    Antimicrob Agents Chemother; 1992 Feb; 36(2):486-8. PubMed ID: 1605618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of amphotericin B colloidal dispersion compared with those of amphotericin B deoxycholate suspension for treatment of disseminated murine cryptococcosis.
    Hostetler JS; Clemons KV; Hanson LH; Stevens DA
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2656-60. PubMed ID: 1482133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of amphotericin B deoxycholate and liposomal amphotericin B against 604 clinical yeast isolates.
    Montagna MT; Lovero G; Coretti C; De Giglio O; Martinelli D; Bedini A; Delia M; Rosato A; Codeluppi M; Caggiano G
    J Med Microbiol; 2014 Dec; 63(Pt 12):1638-1643. PubMed ID: 25210203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphotericin B formulations: a comparative review of efficacy and toxicity.
    Hamill RJ
    Drugs; 2013 Jun; 73(9):919-34. PubMed ID: 23729001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole.
    Rudramurthy SM; Jatana M; Singh R; Chakrabarti A
    Mycoses; 2013 Jan; 56(1):39-46. PubMed ID: 22519679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphotericin-B colloidal dispersion. A review of its use against systemic fungal infections and visceral leishmaniasis.
    Brogden RN; Goa KL; Coukell AJ
    Drugs; 1998 Sep; 56(3):365-83. PubMed ID: 9777313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphotericin B colloidal dispersion.
    Patel R
    Expert Opin Pharmacother; 2000 Mar; 1(3):475-88. PubMed ID: 11249532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invitro antifungal susceptibilities of Candida species to liposomal amphotericin B, determined using CLSI broth microdilution, and amphotericin B deoxycholate, measured using the Etest.
    Lovero G; Giglio O; Rutigliano S; Diella G; Caggiano G; Montagna MT
    J Med Microbiol; 2017 Mar; 66(2):213-216. PubMed ID: 27959780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of two amphotericin B formulations against Malassezia furfur strains recovered from patients with bloodstream infections.
    Iatta R; Immediato D; Montagna MT; Otranto D; Cafarchia C
    Med Mycol; 2015 Apr; 53(3):269-74. PubMed ID: 25631480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of the efficacy of liposomal amphotericin B and amphotericin B deoxycholate against six species of Zygomycetes in a murine lethal infection model.
    Takemoto K; Yamamoto Y; Kanazawa K
    J Infect Chemother; 2010 Dec; 16(6):388-95. PubMed ID: 20535522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole.
    Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga MT; Miranda Y; del Valle O; Cossum PA; Wallace TL
    J Antimicrob Chemother; 1999 Sep; 44(3):397-401. PubMed ID: 10511410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo antifungal activity of amphotericin B lipid complex: are phospholipases important?
    Swenson CE; Perkins WR; Roberts P; Ahmad I; Stevens R; Stevens DA; Janoff AS
    Antimicrob Agents Chemother; 1998 Apr; 42(4):767-71. PubMed ID: 9559780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species.
    Moore CB; Oakley KL; Denning DW
    Clin Microbiol Infect; 2001 Jan; 7(1):11-6. PubMed ID: 11284937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphotericin B colloidal dispersion: an improved antifungal therapy.
    Guo LS
    Adv Drug Deliv Rev; 2001 Apr; 47(2-3):149-63. PubMed ID: 11311990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of pharmacokinetics and drug distribution in tissue to increased safety of amphotericin B colloidal dispersion in dogs.
    Fielding RM; Singer AW; Wang LH; Babbar S; Guo LS
    Antimicrob Agents Chemother; 1992 Feb; 36(2):299-307. PubMed ID: 1605595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro effects of liposomal amphotericin B, amphotericin B-deoxycholate, and free amphotericin B against fungal strains determined by using MIC and minimal lethal concentration susceptibility studies and time-kill curves.
    Ralph ED; Khazindar AM; Barber KR; Grant CW
    Antimicrob Agents Chemother; 1991 Jan; 35(1):188-91. PubMed ID: 2014976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp.
    Oakley KL; Moore CB; Denning DW
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2726-30. PubMed ID: 9756785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro amphotericin B susceptibility of korean bloodstream yeast isolates assessed by the CLSI broth microdilution method, Etest, and Minimum fungicidal concentration test].
    Park JY; Shin JH; Uh Y; Kim EC; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
    Korean J Lab Med; 2008 Oct; 28(5):346-52. PubMed ID: 18971615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles.
    Moraes Moreira Carraro TC; Altmeyer C; Maissar Khalil N; Mara Mainardes R
    J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.